From the jar to the trial record.
A buyer, whether for a household or for a shelf, meets the claim before the evidence. This order starts with the three checks that do most of the work, teaches the chips, and then walks through the claims most often printed on the jar.
7 pages, in the order that makes the next one easier.
A path is a reading order, not a course. Each step is a page that already exists, with one line on why it comes where it does. Read them in sequence and the self-check at the end should hold no surprises.
Judging quality in a CBG product
Three checks that do most of the work: a certificate for the batch, milligrams on the label, and no disease claims.
Page 1 of 7How we grade
Every page after this one uses the same six rungs and two off-ladder states. Ten minutes here and no chip on the site will surprise you.
Page 2 of 7The shelf says, the record says
Fourteen label lines set beside the trial record, each with its grade. Find the one you have seen.
Page 3 of 7CBG for sleep
A tested null, and the clearest example on the site of what Not supported means.
Page 4 of 7THCA flower
Non-intoxicating off the plant and THC once heated, with the legal split that follows from one reaction.
Page 6 of 7Safety and reporting
Where to report a safety event, and the precautions the registry cannot yet grade.
Page 7 of 7
5 questions, each answered somewhere on the path.
Pick one option per question and press Check. Every correct answer is a fact the site documents, and the feedback links to the page that documents it. Checking runs in your browser; nothing is scored, stored or sent anywhere.
The other three orders.
Formulator · Brand owner · Lab or QA manager. Or start from how we grade, the page every path shares.
The blood-pressure note that appears on CBG pages is mechanistic and safety-relevant, not a benefit claim. CBG shows potent α2-adrenoceptor agonism in vitro, and α2 agonists can lower blood pressure — but no study has measured an actual blood-pressure effect of CBG. If you take blood-pressure medication or have a cardiovascular condition, consult a clinician first.
A learning path orders pages; it does not advise. Nothing on it is a claim that any product does anything for any disease. If you have experienced a possible adverse effect from a cannabinoid product, use the Report a safety event path. Peregrine Biopharma funds the platform and holds no editorial authority.